Authors: BEYER J KRAMAR A MANDANAS R LINKESCH W GREINIX A DROZ JP PICO JL DIEHL A BOKEMEYER C SCHMOLL HJ NICHOLS CR EINHORN LH SIEGERT W

Citation: J. Beyer et al., PROGNOSTIC FACTORS FOR HIGH-DOSE CHEMOTHERAPY (HDCT) AS SALVAGE TREATMENT IN GERM-CELL TUMORS (GCT), Bone marrow transplantation, 22, 1998, pp. 16-16

Authors: BEYER J KRAMAR A MANDANAS R LINKESCH W GREINIX A DROZ JP PICO JL DIEHL A BOKEMEYER C SCHMOLL HJ NICHOLS CR EINHORN LH SIEGERT W

Citation: J. Beyer et al., HIGH-DOSE CHEMOTHERAPY AS SALVAGE TREATMENT IN GERM-CELL TUMORS - A MULTIVARIATE-ANALYSIS OF PROGNOSTIC VARIABLES, Journal of clinical oncology, 14(10), 1996, pp. 2638-2645

Authors: BROUN ER NICHOLS CR MANDANAS R SALZMAN D TURNS M HROMAS R CORNETTA K EINHORN LH

Citation: Er. Broun et al., DOSE-ESCALATION STUDY OF HIGH-DOSE CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS BONE-MARROW SUPPORT IN PATIENTS WITH RECURRENT AND REFRACTORY GERM-CELL TUMORS, Bone marrow transplantation, 16(3), 1995, pp. 353-358

Authors: HANSEN K HUCKS P CARLSON M MANDANAS R

Citation: K. Hansen et al., SEVERE ANEMIA AND NEUTROPENIA ASSOCIATED WITH ACUTE EPSTEIN-BARR-VIRUS INFECTION, Blood, 86(10), 1995, pp. 2532-2532

Authors: MANDANAS R EINHORN LH WHEELER B ANSARI R LUTZ T MILLER ME

Citation: R. Mandanas et al., CARBOPLATIN (CBDCA) PLUS ALPHA-INTERFERON IN METASTATIC NONSMALL CELLLUNG-CANCER - A HOOSIER-ONCOLOGY-GROUP PHASE-II TRIAL, American journal of clinical oncology, 16(6), 1993, pp. 519-521